0001682398-21-000001.txt : 20211216 0001682398-21-000001.hdr.sgml : 20211216 20211216153839 ACCESSION NUMBER: 0001682398-21-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20211216 DATE AS OF CHANGE: 20211216 EFFECTIVENESS DATE: 20211216 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Concentric Analgesics, Inc. CENTRAL INDEX KEY: 0001682398 IRS NUMBER: 472338879 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-425385 FILM NUMBER: 211497678 BUSINESS ADDRESS: STREET 1: 1824 JACKSON STREET STREET 2: SUITE A CITY: SAN FRANCISCO STATE: CA ZIP: 94109 BUSINESS PHONE: 707-313-7200 MAIL ADDRESS: STREET 1: 1824 JACKSON STREET STREET 2: SUITE A CITY: SAN FRANCISCO STATE: CA ZIP: 94109 D 1 primary_doc.xml X0708 D LIVE 0001682398 Concentric Analgesics, Inc. 101 California Street Suite 1210 SAN FRANCISCO CA CALIFORNIA 94111 415-484-7921 DELAWARE None None Corporation true Frank J. Bellizzi c/o Concentric Analgesics, Inc. 101 California Street, Suite 1210 San Francisco CA CALIFORNIA 94111 Executive Officer Director John F. Donovan c/o Concentric Analgesics, Inc. 101 California Street, Suite 1210 San Francisco CA CALIFORNIA 94111 Executive Officer Director Thomas King c/o Concentric Analgesics, Inc. 101 California Street, Suite 1210 San Francisco CA CALIFORNIA 94111 Executive Officer Director Biotechnology Decline to Disclose 06b false 2021-12-01 false true true false 0 40030036 20030036 20000000 $20 mil new money; $30,036.97 upon the exercise of warrants; $20 mil remaining to be sold upon conditional second tranche false 116 0 0 0 false Concentric Analgesics, Inc. /s/ Frank J. Bellizzi, Jr. Frank J. Bellizzi, Jr. Chief Executive Officer 2021-12-16